Title: 2025-2026 Regular Session HB 1494 PN 1748 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1748
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 1494 PN 1748 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1748 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.1494 Session of 2025 INTRODUCED BY BANTA, ROWE, GAYDOS, KAUFFMAN, HAMM, RAPP AND T. JONES, MAY 19, 2025 REFERRED TO COMMITTEE ON HEALTH, MAY 21, 2025 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," providing for over-the-counter availability of ivermectin.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a section to read:Section 13.10. Over-the-Counter Availability of Ivermectin.--(a) Ivermectin suitable for human use may be dispensed, sold or purchased in this Commonwealth as an over-the-counter medication without a prescription or consultation with a pharmacist, physician or other health care practitioner.(b) As used in this section, the term "over-the-counter 12345678910111213141516171819202122 medication" means a drug that may be legally dispensed, sold and purchased without a prescription in accordance with Federal and State law.Section 2. This act shall take effect in 60 days.20250HB1494PN1748 - 2 - 1234


================================================================================

Raw Text:
2025-2026 Regular Session HB 1494 PN 1748 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1748 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.1494 Session of 2025 INTRODUCED BY BANTA, ROWE, GAYDOS, KAUFFMAN, HAMM, RAPP AND T. JONES, MAY 19, 2025 REFERRED TO COMMITTEE ON HEALTH, MAY 21, 2025 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," providing for over-the-counter availability of ivermectin.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a section to read:Section 13.10. Over-the-Counter Availability of Ivermectin.--(a) Ivermectin suitable for human use may be dispensed, sold or purchased in this Commonwealth as an over-the-counter medication without a prescription or consultation with a pharmacist, physician or other health care practitioner.(b) As used in this section, the term "over-the-counter 12345678910111213141516171819202122 medication" means a drug that may be legally dispensed, sold and purchased without a prescription in accordance with Federal and State law.Section 2. This act shall take effect in 60 days.20250HB1494PN1748 - 2 - 1234